Showing results (151-160 of 579) with videos related to
Sort By:
Pageof 58
Cancer|May 1, 1991
Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patientsR Dummer, W Müller, F Nestle, et al.Cancer Gene Therapy|August 5, 2000
Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumorsR Dummer, J Bergh, Y Karlsson, et al.The American Journal of Pathology|September 11, 2001
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 productionM Urosevic, M O Kurrer, J Kamarashev, et al.The British Journal of Dermatology|March 26, 2003
Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literatureG Burg, W Kempf, D V Kazakov, et al.Current Opinion in Investigational Drugs (London, England : 2000)|September 27, 2001
GVAX (Cell Genesys)R DummerMelanoma Research|April 1, 1997
D1 dopamine receptors are not expressed in human melanomaR Böni, W Lichtensteiger, H C Steinert, et al.The British Journal of Dermatology|April 1, 1995
Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucoseR Böni, R A Böni, H Steinert, et al.The Journal of Investigative Dermatology|January 1, 1992
Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo?R Dummer, G Posseckert, F Nestle, et al.Dermatology (Basel, Switzerland)|July 2, 2003
Treatment of verrucous carcinoma with imiquimod and CO2 laser ablationL M Heinzerling, W Kempf, J Kamarashev, et al.The Journal of Investigative Dermatology|July 1, 1995
Direct and indirect control of T-cell activation by keratinocytesB J Nickoloff, L A Turka, R S Mitra, et al.Pageof 58